Successful Grant Applications for LifeScience Projects
Einreichungsfristen der wichtigsten deutschen und internationalen Förderprogramme
Um im Bereich Forschung und Entwicklung von Förderprogrammen profitieren zu können, müssen die erforderlichen Anträge rechtzeitig eingereicht werden. Sowohl deutsche als auch internationale Förderprogramme für Forschung und Entwicklung gehen meistens mit festen Fristen für die Programme einher. Wenn Sie sich über die Einreichungsfristen der wichtigsten deutschen und internationalen Förderprogramme informieren möchten, werden Sie hier fündig. Wir fassen für Sie die wichtigsten Fristen der Möglichkeiten zur Förderung im Folgenden übersichtlich zusammen; die letzte Aktualisierung erfolgte am 27. Mai 2025 (Angaben ohne Gewähr). Zu den regionalen Programmen der einzelnen Bundesländer sprechen Sie uns bitte direkt an.
Diese Seite ist thematisch gegliedert: unter jedem Forschungsbereich (Gesundheit; Biotech/Bioökonomie; IT in Life Sciences; Start-up-Programme; Pflanzen, Umwelt, Klima, Landwirtschaft; „buttom up approaches“ - offen für alle Themen; internationale Partnerschaften) finden Sie deutsche, EU- und andere internationale Programme).
Sie haben Fragen zu einer bestimmten für Forschung und Entwicklung bereitstehenden Förderung? Dann sprechen Sie uns an (Tel: +493077205920; Email: info@consultech.de). Wir informieren Sie gern umfassend!
Gesundheit
Deutsche Programme
Horizon Europe
Legende:
CSA = Coordination and Support Actions (100% funding rate)
RIA = Research and Innovation Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
RIA = Research and Innovation Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
| Call-ID | Topic | Funding per project [in Mio €] |
Funding rate | Call-budget [in Mio €] |
Process [stages] |
Deadline |
|---|---|---|---|---|---|---|
| HORIZON-MISS-2025-06-CIT-CANCER-01 | Increasing walking and cycling: to reap health benefits, emission reductions and integrate active mobility and micro-mobility devices, with smart technologies and infrastructure | 6 | IA | 12 | 1 | 04.09.2025 |
| HORIZON-MISS-2025-02-CANCER-01 | Sustained collaboration of national and regional cancer funders to support the Cancer Mission through translational research | 5 | CSA | 5 | 1 | 16.09.2025 |
| HORIZON-MISS-2025-02-CANCER-02 | Understanding the effects of environmental exposure on the risk of paediatric, adolescent and young adult cancers | 30,5 | RIA | 6-7 | 1 | 16.09.2025 |
| HORIZON-MISS-2025-02-CANCER-03 | Innovative surgery as the cornerstone of affordable multi-modal therapeutic interventions benefitting cancer patients with locally advanced or metastatic disease | 31 | RIA | 7-10 | 1 | 16.09.2025 |
| HORIZON-MISS-2025-02-CANCER-04 | Investigator-initiated multinational early-stage innovative clinical trials for paediatric cancer | 25 | RIA | 6-8 | 1 | 16.09.2025 |
| HORIZON-MISS-2025-02-CANCER-05 | Pragmatic clinical trials to enhance the quality of life of older cancer patients (65 years and older) through nutrition | 15 | RIA | 3-5 | 1 | 16.09.2025 |
| HORIZON-MISS-2025-02-CANCER-06 | Support to the network of National Cancer Mission Hubs (NCMHs) | 11 | CSA | 11 | 1 | 16.09.2025 |
| HORIZON-HLTH-2025-01-DISEASE-01 | Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections | 15 | RIA | 45 | 1 | 16.09.2025 |
| HORIZON-HLTH-2025-01-DISEASE-03 | Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential | 10 | RIA | 50 | 1 | 16.09.2025 |
| HORIZON-HLTH-2025-01-DISEASE-04 | Leveraging artificial intelligence for pandemic preparedness and response | 6 to 8 | RIA | 35 | 1 | 16.09.2025 |
| HORIZON-HLTH-2025-01-DISEASE-05 | Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) | 2 | CSA | 2 | 1 | 16.09.2025 |
| HORIZON-HLTH-2025-01-DISEASE-06 | Implementation research addressing strategies to strengthen health systems for equitable high-quality care and health outcomes in the context of non-communicable diseases (GACD) | 3 to 4 | RIA | 20 | 1 | 16.09.2025 |
| HORIZON-HLTH-2025-01-DISEASE-07 | Tackling high-burden for patients and under-researched medical conditions | 6 | RIA | 30 | 1 | 16.09.2025 |
| HORIZON-HLTH-2025-01-CARE-01 | End user-driven application of Generative Artificial Intelligence models in healthcare (GenAI4EU) | 15 to 20 | RIA | 10 | 1 | 16.09.2025 |
| HORIZON-HLTH-2025-01-TOOL-01 | Enhancing cell therapies with genomic techniques | 8 to 10 | RIA | 50 | 1 | 16.09.2025 |
| HORIZON-HLTH-2025-01-TOOL-02 | Advancing cell secretome-based therapies | 9 to 13 | RIA | 40 | 1 | 16.09.2025 |
| HORIZON-HLTH-2025-01-TOOL-03 | Leveraging multimodal data to advance Generative Artificial Intelligence applicability in biomedical research (GenAI4EU) | 15 to 17 | RIA | 50 | 1 | 16.09.2025 |
| HORIZON-HLTH-2025-01-TOOL-05 | Boosting the translation of biotech research into innovative health therapies | 4 to 8 | RIA | 80 | 1 | 16.09.2025 |
| HORIZON-HLTH-2025-01-IND-01 | Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs) | 6 to 8 | IA | 40 | 1 | 16.09.2025 |
| HORIZON-HLTH-2025-01-IND-02 | Digitalisation of conformity assessment procedures of medical devices and in vitro diagnostic medical devices | 4 | CSA | 4 | 1 | 16.09.2025 |
| HORIZON-HLTH-2025-03-STAYHLTH-01-two-stage | Improving the quality of life of persons with intellectual disabilities and their families | 6 to 8 | RIA | 40 | 2 | 16.09.2025 16.04.2026 |
| HORIZON-HLTH-2025-03-ENVHLTH-01-two-stage | The impact of pollution on the development and progression of brain diseases and disorders | 6 to 7 | RIA | 40 | 2 | 16.09.2025 16.04.2026 |
| HORIZON-HLTH-2025-03-ENVHLTH-02-two-stage | Advancing knowledge on the impacts of micro- and nanoplastics on human health | 7 to 8 | RIA | 40 | 2 | 16.09.2025 16.04.2026 |
| HORIZON-HLTH-2025-03-DISEASE-02-two-stage | Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders | 6 to 8 | RIA | 50 | 2 | 16.09.2025 16.04.2026 |
| HORIZON-HLTH-2025-03-IND-03-two-stage | Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices | 6 to 8 | RIA | 40 | 2 | 16.09.2025 16.04.2026 |
| HORIZON-CL6-2025-02-FARM2FORK-12 | Nutrition and Mental Health | 5 | RIA | 10 | 1 | 16.09.2025 |
| HORIZON-CL2-2025-01-TRANSFO-08 | Improving mental health outcomes for people in education, training and work | 0,3-0,5 | RIA | 15 | 1 | 16.09.2025 |
| HORIZON-MISS-2025-01-CLIMA-04 | Testing and demonstrating innovative solutions to improve resilience to extreme heat, including addressing health impacts | 10 | IA | 30 | 1 | 24.09.2025 |
| HORIZON-EIC-2025-PATHFINDERCHALLENGES-01-02 | EIC pathfinder challenge: Generative-AI based Agents to Revolutionize Medical Diagnosis and Treatment of Cancer | 4 | 100% | 120 (all challenges) | 1 | 29.10.2025 |
Andere internationale Programme
| Funding Organisation / Programme | Title/ Topic | Deadline |
|---|---|---|
| Innovative Health Initiative (IHI 11) | Towards precision medicine: platform for transdiagnostic stratification of brain dysfunction | tba |
| Innovative Health Initiative (IHI 11) | Understanding how infections foster and induce non-communicable diseases | tba |
| Innovative Health Initiative (IHI 11) | AI-powered signal detection in pharmacovigilance | tba |
| Innovative Health Initiative (IHI 11) | Leveraging Europe's expertise to accelerate cell therapy for type 1 diabetes | tba |
| Innovative Health Initiative (IHI 11) | Establishing ortho and cardiology ambulatory surgical centres in Europe | tba |
| CEPI - Coalition for Epidemic Preparedness Innovations | Innovations to Prepare for Future Epidemics and Pandemics: Focus Area 1: advancing innovative rapid-response vaccine platforms that can transform the response to a future Disease X | Roling until 2026 |
| CEPI - Coalition for Epidemic Preparedness Innovations | Innovations to Prepare for Future Epidemics and Pandemics: Focus Area 2: developing new vaccine candidates against CEPI priority pathogens with epidemic or pandemic potential and viral families | Roling until 2026 |
| CEPI - Coalition for Epidemic Preparedness Innovations | Vaccine development and manufacturing: Innovations to Prepare for Future Epidemics and Pandemics | 31.12.2026 |
Biotechnologie/Bioökonomie
Deutsche Programme
| Programm | Einreichungsfrist |
|---|---|
| BMBF: Materialinnovationen für ein gutes und sicheres Leben (MaterialVital) Modul 1 – Biohybride und lebende Materialsysteme | 27.05.2025 |
| BMBF: Vermeidung von klimarelevanten Prozessemissionen in der Industrie (KlimPro-Industrie II) u.a.: neue biogene Kohlenstoffquellen | 30.06.2025 |
| BMEL: Entwicklung und Anwendung biobasierter Additive | 30.06.2025 |
| Deutsche Innovationspartnerschaft Agrar (DIP) - Innovationsförderung | 15.08.2025 |
| BMBF: Go-Bio next | 15.09.2025 |
| BMWK: Industrielle Bioökonomie. Bausteine A, B, D | 15.10.2025 |
| BMBF: KMU-innovativ Bioökonomie | 15.10.2025 |
| BMBF: KMU-innovativ Ressourcen und Kreislaufwirtschaft (Themen: Wassermanagement, Kreislaufwirtschaft) | 15.10.2025 |
| BMBF: Go-Bio initial | 15.02.2026 |
| BMBF: Kreativer Nachwuchs forscht für die Bioökonomie | 15.04.2026 |
Horizon Europe
Legend:
CSA = Coordination and Support Actions (100% funding rate)
RIA = Research and Innovation Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
RIA = Research and Innovation Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
| Call-ID | Deadline | Topic | Funding per project [in Mio €] |
Funding rate | Call-budget [in Mio €] |
Process [stages] |
|---|---|---|---|---|---|---|
| HORIZON-CL6-2025-01-CIRCBIO-01-two-stage | 04.09.2025 (1st stage) 18.02.2026 (2nd stage) |
Open Topic: Innovative solutions for the sustainable and circular transformation of SMEs | 5 | IA | 10 | 2 |
| HORIZON-CL6-2025-02-FARM2FORK-13 | 16.09.2025 | Raising citizen awareness on alternative proteins derived from biotechnology | 2 | CSA | 2 | 1 |
| HORIZON-CL6-2025-02-FARM2FORK-14 | 16.09.2025 | Nutrients produced by microorganisms utilising primarily CO2 from the air, with the support of biotechnology | 6 | IA | 12 | 1 |
| HORIZON-HLTH-2025-01-TOOL-02 | 16.09.2025 | Advancing cell secretome-based therapies | 9-13 | RIA | 40 | 1 |
| HORIZON-HLTH-2025-01-TOOL-05 | 16.09.2025 | Boosting the translation of biotech research into innovative health therapies | 4 to 8 | RIA | 80 | 1 |
| HORIZON-HLTH-2025-01-IND-01 | 16.09.2025 | Optimising the manufacturing of Advanced Therapy Medicinal Products (ATMPs) | 6 to 8 | IA | 40 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-01 | 17.09.2025 | Novel circular business models to enable the just transition to a sustainable and circular economy | 5 | IA | 10 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-02 | 17.09.2025 | Improving ecodesign of products and development of testing methods for products prioritised under the Ecodesign for Sustainable Products Regulation | 4 | RIA | 8 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-03 | 17.09.2025 | Product Environmental Footprint (PEF) of policy and market-relevant product groups | 4 | RIA | 8 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-04 | 17.09.2025 | Development and testing of Extended Producer Responsibility schemes (EPR) within the priority Circular Economy Action Plan value chains | 5 | IA | 10 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-05 | 17.09.2025 | Consumption patterns and environmental awareness as enablers of transition to circular economy | 6 | IA | 12 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-06 | 17.09.2025 | Indicators for the transition to sustainable and circular economy | 4 | RIA | 8 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-07 | 17.09.2025 | Demonstration, deployment and upscaling of circular systemic solutions in cities and regions(Circular Cities and Regions Initiative) | 9 | IA | 18 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-08 | 17.09.2025 | Bioprospecting and optimized production of the terrestrial natural products: new opportunities for bio-based sectors | 5,5 | IA | 11 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-09 | 17.09.2025 | Unleashing the potential and advancing the impact of the digitalization/Artificial Intelligence of the climate-neutral bio-based value chains | 5 | IA | 10 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-10 | 17.09.2025 | Support to the EU Biotechnology and Biomanufacturing Initiative: scoping action | 2 | CSA | 2 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-11 | 17.09.2025 | Demonstration of reduced energy use and optimised flexible energy supply for industrial bio-based systems | 5,5 | IA | 11 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-12 | 17.09.2025 | Harmonizing and optimising composting plants performances in Europe | 2 | CSA | 2 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-13 | 17.09.2025 | Reconstructing areas affected by conflicts: the role of the bio-based solutions | 4 | RIA | 8 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-14 | 17.09.2025 | Bioprospecting and optimised production of marine/aquatic natural products in the omics & artificial intelligence era | 6 | IA | 12 | 1 |
| HORIZON-CL6-2025-01-CIRCBIO-15 | 17.09.2025 | European partnership: Forests and Forestry for a Sustainable Future | 70 | COFUND | 70 | 1 |
| HORIZON-CL6-2025-01-ZEROPOLLUTION-03 | 17.09.2025 | Environmental biotechnology applications in service of remediation of polluted ecosystems | 4 | RIA | 8 | 1 |
| HORIZON-CL6-2025-01-ZEROPOLLUTION-07 | 17.09.2025 | Reducing pollution from the food and drink industries | 6 | IA | 12 | 1 |
| HORIZON-CL4-2025-05-TWIN-TRANSITION-35-two-stage | 23.09.2025 (1st stage) 14.04.2025 (2nd stage) |
Developing and embedding upcycling technologies into viable business (Processes4Planet partnership) | 8-12 | IA | 48 | 2 |
| HORIZON-CL6-2025-03-GOVERNANCE-04 | 24.09.2025 | Operationalisation of bioeconomy sustainability principles | 4 | RIA | 8 | 1 |
| HORIZON-CL6-2025-03-GOVERNANCE-06 | 24.09.2025 | Strengthening and connecting bioeconomy networks | 4,4 | CSA | 4,4 | 1 |
| HORIZON-CL6-2025-03-GOVERNANCE-07 | 24.09.2025 | Strengthening the European Research Area by enhancing the bioeconomy research and innovation ecosystem in BIOEAST countries | 4 | CSA | 4 | 1 |
| HORIZON-EIC-2025-ACCELERATOR-01 | 01.10.2025 (full proposal) | EIC accelerator challenge: Biotechnology driven low emission food production systems | 2,5 + investment | 70% | 250 (all acc.challenges) | 3 |
| HORIZON-EIC-2025-PATHFINDERCHALLENGES-01-01 | 29.10.2025 | EIC pathfinder: Biotech for Climate Resilient Crops and Plant-Based Biomanufacturing | 4 | 100% | 120 (all path. challenges | 2 |
| HORIZON-EIC-2025-PATHFINDERCHALLENGES-01-04 | 29.10.2025 | EIC pathfinder: Waste-to-value devices - circular production of renewable fuels, chemicals and materials | 4 | 100% | 120 (all path. challenges | 2 |
| HORIZON-NEB-2025-01-REGEN-02 | 12.11.2025 | Bio-fabricated materials for sustainable and beautiful construction | 5 | RIA | 10 | 1 |
Andere internationale Programme
Keine aktuellen Förderbekanntmachungen
IT in LifeSciences
Deutsche Programme
| Programm | Einreichungsdatum |
|---|---|
| BMBF: Forschungsvorhaben zur Verbesserung der Explorations- und Integrationsphasen der IKT-Forschung | laufend |
| BMBF: DataXperiment - Erprobung innovativer Machbarkeits- und Anwendungsszenarien in der Onkologie - Nationale Dekade gegen Krebs - | 30.05.2025 |
| BMBF: Forschungs- und Entwicklungsprojekte zwischen Deutschland und dem Westbalkan in den Querschnittsbereichen: Digitale Transformation, Green Deal und Gesunde Gesellschaften | 11.06.2025 |
| BMBF: START-interaktiv - Interaktive Technologien für Gesundheit und Lebensqualität | 15.07.2025 |
| BMBF: KMU-innovativ Informations- und Kommunikationstechnologien | 15.10.2025 |
| BMBF: KMU-innovativ Interaktive Technologien für Gesundheit und Lebensqualität | 15.04.2025 |
| BMBF: KMU-innovativ Informations- und Kommunikationstechnologien | 15.04.2026 |
| BMBF: KMU-innovativ Interaktive Technologien für Gesundheit und Lebensqualität | 15.04.2026 |
Horizon Europe
Legend:
CSA = Coordination and Support Actions (100% funding rate)
RIA = Research and Innovation Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
RIA = Research and Innovation Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
Andere internationale Programme
Keine aktuellen Förderbekanntmachungen
Start-up Programme
Deutsche Programme
| Programm | Einreichungsdatum |
|---|---|
| BMBF: VIP+ "Validierung des technologischen und gesellschaftlichen Innovationspotenzials wissenschaftlicher Forschung" (vor Gründung) | laufend |
| BMBF: Enabling Start-up: Unternehmensgründungen in den Quantentechnologien und der Photonik | laufend |
| DBU: Green Start-up-Programm | laufend |
| BMBF: Kreativer Nachwuchs forscht für die Bioökonomie | 15.04.2025 |
| BMBF: START-interaktiv: Interaktive Technologien für Gesundheit und Lebensqualität | 15.07.2025 |
| BMWK: EXIST-Forschungstransfer, (Existenzgründungen aus der Wissenschaft) | 31.08.2025 |
| BMBF: Go-Bio next | 15.09.2025 |
| BMWK: EXIST-Forschungstransfer, (Existenzgründungen aus der Wissenschaft) | 30.11.2025 |
| BMBF: Go-Bio next | 15.03.2026 |
Horizon Europe
Legend:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
| Call-ID | Deadline | Topic | Funding per project [in Mio €] |
Funding rate | Call-budget [in Mio €] |
Process [stages] |
|---|---|---|---|---|---|---|
| EIC Transition (Proposals must build on eligible EU-funded project results) | *** overall budget transition challenges | |||||
| tba | 17.09.2025 | EIC Transition Open | 2.5 | 100% | 98 | 1 |
| tba | not in 2025 | EC Transition Challenges | tba | 100% | tba | 1 |
| EIC Accelerator |
* overall budget accelerator challenges | |||||
| tba | 12.03.2025 01.10.2025 |
EIC Accelerator 2025 Open | max. 2,5 Mio grant + 0.5-10 Mio investment | 70% | 384 | 3 (first stage proposal at any time) |
| tba | 12.03.2025 01.10.2025 |
EIC Accelerator Challenge: Acceleration of advanced materials development and upscaling along the value chain (energy, mobility, electronics, construction) | max. 2,5 Mio grant + 0.5-10 Mio investment | 70% | 250* | 3 (first stage proposal at any time) |
| tba | 12.03.2025 01.10.2025 |
EIC Accelerator Challenge: Biotechnology driven low emission food production systems | max. 2,5 Mio grant + 0.5-10 Mio investment | 70% | 250* | 3 (first stage proposal at any time) |
| tba | 12.03.2025 01.10.2025 |
EIC Accelerator Challenge: GenAI4EU: Creating European Champions in Generative AI | max. 2,5 Mio grant + 0.5-10 Mio investment | 70% | 250* | 3 (first stage proposal at any time) |
| tba | 12.03.2025 01.10.2025 |
EIC Accelerator Challenge: Innovative in-space servicing, operations, space-based robotics and technologies for resilient EU space infrastructure | max. 2,5 Mio grant + 0.5-10 Mio investment | 70% | 250* | 3 (first stage proposal at any time) |
| tba | 12.03.2025 01.10.2025 |
EIC Accelerator challenge: Breakthrough innovations for future mobility | max. 2,5 Mio grant + 0.5-10 Mio investment | 70% | 250* | 3 (first stage proposal at any time) |
| EIC Accelerator STEP scale-up call | ||||||
| tba | at any time | Scaling up strategic technologies for Europe | 10-30 investment | - | 300 | 2 |
Pflanzen, Umwelt, Klima, Agrar, Biodiversität
Deutsche Programme
| Programm | Einreichungsfrist |
|---|---|
| BMEL: Innovationen in Haltungssystemen in der landwirtschaftlichen Tierhaltung | 02.04.2025 |
| BMBF: KMU-innovativ Bioökonomie | 15.04.2025 |
| BMBF: KMU-innovativ Ressourcen und Kreislaufwirtschaft (Themen: Wassermanagement, Kreislaufwirtschaft) | 15.04.2025 |
| BMEL: Förderung der wirtschaftlichen Innovationskraft für einen klimaangepassten Umgang mit der Ressource Wasser | 29.04.2025 |
| BLE: Durchführung von Status-quo- und Wissensstandanalysen im ökologischen Landbau | 16.05.2025 |
| BMBF: Internationale Verbundvorhaben im Bereich wissenschaftlicher Forschung und Innovation durch die Mitglieder der EU-LAK-Interessengruppe | 22.05.2025 |
| Deutsche Innovationspartnerschaft Agrar (DIP) - Innovationsförderung | 15.08.2025 |
Horizon Europe
Legend:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
| Call-ID | Deadline | Topic | Funding per project [in Mio €] |
Funding rate | Call-budget [in Mio €] |
Process [stages] |
|---|---|---|---|---|---|---|
| tba | 29.10.2025 | EIC pathfinder: Biotech for Climate Resilient Crops and Plant-Based Biomanufacturing | 4 | 100% | 120 (all path. challenges) | 1 |
| DRS-01-01 | 20.11.2024 | Prevention, detection, response and mitigation of chemical, biological and radiological threats to agricultural production, feed and food processing, distribution and consumption | around 4 | RIA | 8 | 1 |
Andere internationale Programme
| Funding Organisation / Programme |
Title / Topic | Deadline |
|---|---|---|
| CBE JU | Retrofitting of (bio)refineries industrial plants towards higher-value bio-based products (IA flagship) | 17.09.2025 |
| CBE JU | Sustainable macroalgae systems for innovative, added-value applications: cultivation and optimised production systems (IA) | 17.09.2025 |
| CBE JU | Bio-based and biodegradable delivery systems for fertilising products to reduce microplastics pollution & promote soil health (RIA) | 17.09.2025 |
Themenoffen
Deutsche Programme
| Programm | Einreichungsfrist |
|---|---|
| Bund: Steuerliche Forschungszulage - für alle F&E Aktivitäten, auch rückwirkend | laufend |
| BMWK: Zentrales Innovationsprogramm Mittelstand - ZIM (themenoffen) | laufend |
| BMWK: ZIM international - verschiedene Länderpartnerschaften mit Deutschland | verschiedene Fristen |
| BMBF: VIP+ "Validierung des technologischen und gesellschaftlichen Innovationspotenzials wissenschaftlicher Forschung" | laufend |
| STARK – Stärkung der Transformationsdynamik und Aufbruch in den Revieren und an den Kohlekraftwerkstandorten (verschiedene Themen, siehe Bekanntmachung) | laufend |
| Förderung von Maßnahmen zur Unterstützung von Hochschulen für Angewandte Wissenschaften (HAW) bei der internationalen Vernetzung und bei der Antragstellung | laufend |
| SPRIND (Sprunginnovationen) | laufend |
| EUREKA: Eurostars | tba |
| IraSME: 36. Call | tba |
Horizon Europe
Legend:
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
CSA = Coordination and Support Actions (100% funding rate)
IA = Innovative Action (70% funding rate)
mHealth = mobile health
PcoA = Programme Co-fund Action
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
PCP = Pre-Commercial Procurement
PPI = Public procurement of innovative solutions
RIA = Research and Innovation Actions (100% funding rate)
| Call-ID | Deadline | Topic | Funding per project [in Mio €] |
Funding rate | Call-budget [in Mio €] |
Process [stages] |
|---|---|---|---|---|---|---|
| tba | not in 2025 | EIC Transition Open | 2,5 | 100% | tba | 1 |
| tba | 12.03.2025 01.10.2025 |
EIC Accelerator Open | max. 2,5 Mio grant + 0.5-10 Mio investment | 70% | 384 | 3 |
| tba | 21.05.2025 | EIC Pathfinder Open | tba | 100% | 142 | 1 |
Andere internationale Programme
| Programm | Einreichungsdatum |
|---|---|
| BMWK: ZIM international - verschiedene Länderpartnerschaften mit Deutschland | verschiedene Deadlines |
| EUREKA: Eurostars | 13.03.2025 |
| IraSME – International research activities by small and medium-sized enterprises: 35th call | 26.03.2025 |
| 39. CORNET Call | 26.03.2025 |
Partnerschaften